Portfolio (Quarterly)
Guide ↗
Boxer Capital Management, LLC
· CIK 0002018299| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 250,000.0 | $3.6M | 1.16% | NEW | — | $14.52 | +41.0% |
| 22 | PGEN | PRECIGEN INC | Healthcare | 850,000.0 | $2.8M | 0.89% | NEW | — | $3.29 | +134.0% |
| 23 | — | APOGEE THERAPEUTICS INC | — | 50,000.0 | $2.0M | 0.63% | NEW | — | $39.73 | — |
| 24 | — | MIND MEDICINE MINDMED INC | — | 163,500.0 | $1.9M | 0.61% | NEW | — | $11.79 | — |
| 25 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 250,000.0 | $1.8M | 0.57% | NEW | — | $7.17 | +69.0% |
| 26 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 175,000.0 | $1.6M | 0.52% | — | — | $9.24 | +156.0% |
| 27 | — | AVALO THERAPEUTICS INC | — | 125,000.0 | $1.6M | 0.51% | NEW | — | $12.71 | — |
| 28 | MIST | MILESTONE PHARMACEUTICALS IN | Healthcare | 666,666.0 | $1.3M | 0.42% | NEW | — | $2.00 | -60.3% |
| 29 | PEPG | PEPGEN INC | Healthcare | 250,000.0 | $1.2M | 0.37% | NEW | — | $4.62 | -42.0% |
| 30 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 70,000.0 | $1.1M | 0.35% | NEW | — | $15.79 | +139.4% |
| 31 | — | INSTIL BIO INC | — | 60,700.0 | $1.1M | 0.35% | -10K | -14.1% | $17.86 | — |
| 32 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 20,400.0 | $248K | 0.08% | -73K | -78.2% | $12.18 | +121.7% |
| 33 | — | NUVATION BIO INC | — | 266,666.0 | $54K | 0.02% | — | — | $0.20 | — |
| 34 | — | SURROZEN INC | — | 66,666.0 | $1K | — | — | — | $0.01 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%